Literature DB >> 20303835

p21CDKN1A participates in base excision repair by regulating the activity of poly(ADP-ribose) polymerase-1.

Ornella Cazzalini1, Francesca Donà, Monica Savio, Micol Tillhon, Cristina Maccario, Paola Perucca, Lucia A Stivala, A Ivana Scovassi, Ennio Prosperi.   

Abstract

The cell cycle inhibitor p21(CDKN1A) has been shown to participate in nucleotide excision repair by interacting with PCNA. Here we have investigated whether p21 plays a role in base excision repair (BER), by analyzing p21 interactions with BER factors, and by assessing the response of p21(-/-) human fibroblasts to DNA damage induced by alkylating agents. Absence of p21 protein resulted in a higher sensitivity to alkylation-induced DNA damage, as indicated by reduced clonogenic efficiency, defective DNA repair (assessed by the comet test), and by persistence of histone H2AX phosphorylation. To elucidate the mechanisms at the basis of the function of p21 in BER, we focused on its interaction with poly(ADP-ribose) polymerase-1 (PARP-1), an important player in this repair process. p21 was found to bind the automodification/DNA binding domain of PARP-1, although some interaction occurred also with the catalytic domain after DNA damage. This association was necessary to regulate PARP-1 activity since poly(ADP-ribosylation) induced by DNA damage was higher in p21(-/-) human fibroblasts than in parental p21(+/+) cells, and in primary fibroblasts after p21 knock-down by RNA interference. Concomitantly, recruitment of PARP-1 and PCNA to damaged DNA was greater in p21(-/-) than in p21(+/+) fibroblasts. This accumulation resulted in persistent interaction of PARP-1 with BER factors, such as XRCC1 and DNA polymerase beta, suggesting that prolonged association reduced the DNA repair efficiency. These results indicate that p21 regulates the interaction between PARP-1 and BER factors, to promote efficient DNA repair. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20303835     DOI: 10.1016/j.dnarep.2010.02.011

Source DB:  PubMed          Journal:  DNA Repair (Amst)        ISSN: 1568-7856


  18 in total

1.  Comparison of human lung cancer cell radiosensitivity after irradiations with therapeutic protons and carbon ions.

Authors:  Otilija D Keta; Danijela V Todorović; Tanja M Bulat; Pablo Ga Cirrone; Francesco Romano; Giacomo Cuttone; Ivan M Petrović; Aleksandra M Ristić Fira
Journal:  Exp Biol Med (Maywood)       Date:  2016-09-15

2.  DDB2 association with PCNA is required for its degradation after UV-induced DNA damage.

Authors:  Ornella Cazzalini; Paola Perucca; Roberto Mocchi; Sabrina Sommatis; Ennio Prosperi; Lucia Anna Stivala
Journal:  Cell Cycle       Date:  2013-11-04       Impact factor: 4.534

Review 3.  Mechanistic insight into DNA damage and repair in ischemic stroke: exploiting the base excision repair pathway as a model of neuroprotection.

Authors:  Peiying Li; Xiaoming Hu; Yu Gan; Yanqin Gao; Weimin Liang; Jun Chen
Journal:  Antioxid Redox Signal       Date:  2010-12-02       Impact factor: 8.401

Review 4.  BERing the burden of damage: Pathway crosstalk and posttranslational modification of base excision repair proteins regulate DNA damage management.

Authors:  Kristin L Limpose; Anita H Corbett; Paul W Doetsch
Journal:  DNA Repair (Amst)       Date:  2017-06-09

5.  Bioluminescence imaging captures the expression and dynamics of endogenous p21 promoter activity in living mice and intact cells.

Authors:  Kelsey L Tinkum; Luciano Marpegan; Lynn S White; Jinwu Sun; Erik D Herzog; David Piwnica-Worms; Helen Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2011-07-26       Impact factor: 4.272

6.  The PARP inhibitor PJ34 causes a PARP1-independent, p21 dependent mitotic arrest.

Authors:  Dana L Madison; Daniel Stauffer; James R Lundblad
Journal:  DNA Repair (Amst)       Date:  2011-08-12

7.  Epigallocatechin-3-gallate prevents autoimmune-associated down- regulation of p21 in salivary gland cells through a p53-independent pathway.

Authors:  Douglas Dickinson; Hongfang Yu; Seiji Ohno; Cristina Thomas; Scott Derossi; Yat-Ho Ma; Nicole Yates; Emily Hahn; Frederick Bisch; Tetsuya Yamamoto; Stephen Hsu
Journal:  Inflamm Allergy Drug Targets       Date:  2014-02

8.  Synergistic interaction between the HDAC inhibitor, MPT0E028, and sorafenib in liver cancer cells in vitro and in vivo.

Authors:  Jing-Ping Liou; Shiow-Lin Pan; Che-Ming Teng; Chun-Han Chen; Mei-Chuan Chen; Jing-Chi Wang; An-Chi Tsai; Ching-Shih Chen
Journal:  Clin Cancer Res       Date:  2014-02-11       Impact factor: 12.531

9.  A Novel Inhibitor of Topoisomerase I Is Selectively Toxic for a Subset of Non-Small Cell Lung Cancer Cell Lines.

Authors:  Iryna O Zubovych; Anirudh Sethi; Aditya Kulkarni; Vural Tagal; Michael G Roth
Journal:  Mol Cancer Ther       Date:  2015-12-14       Impact factor: 6.261

10.  PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?

Authors:  Amanda F Swindall; Jennifer A Stanley; Eddy S Yang
Journal:  Cancers (Basel)       Date:  2013-07-26       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.